alexa
Reach Us +1-504-608-239
Editor - Holly Brunton | University of Glasgow | 18347
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Holly Brunton

Holly Brunton
Holly Brunton
Research Associate
Wolfson Wohl Cancer Research Centre
Institute of Cancer Sciences
University of Glasgow
United Kingdom
University of Glasgow

Biography

Holly Brunton is currently a Research Associate in the laboratory of Professor Andrew Biankin at the Wolfson Wohl Cancer Research Centre, which is part of the Institute of Cancer Sciences at the University of Glasgow. Primary research efforts are focused towards advancing genotype guided stratified therapy for pancreatic cancer. Holly completed her doctorate in Biochemistry at the University of Sussex in 2011, studying DNA double strand break repair in the context of higher order chromatin structure. Holly joined the National Institute of Radiological Sciences, Japan, in 2011 as a Research Associate analyzing the effect of heavy-ion radiation on cell cycle arrest. In 2012, Holly moved to Manchester to work within the Molecular Cancer Studies department at the University of Manchester. Here, she investigated mechanisms of resistance to targeted cancer therapy in melanoma.

Research Interest

Cancer Biology
Oncology
Targeted cancer therapy
Personalised medicine
DNA damage

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top